rs373400596
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 6P and 2B. PM1PM2PM5BP4BP6
The NM_198253.3(TERT):c.3150G>C(p.Lys1050Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000595 in 1,613,760 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K1050E) has been classified as Pathogenic.
Frequency
Consequence
NM_198253.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TERT | NM_198253.3 | c.3150G>C | p.Lys1050Asn | missense_variant | 14/16 | ENST00000310581.10 | NP_937983.2 | |
TERT | NM_001193376.3 | c.2961G>C | p.Lys987Asn | missense_variant | 13/15 | NP_001180305.1 | ||
TERT | NR_149162.3 | n.2858G>C | non_coding_transcript_exon_variant | 11/13 | ||||
TERT | NR_149163.3 | n.2822G>C | non_coding_transcript_exon_variant | 11/13 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000525 AC: 8AN: 152270Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000928 AC: 23AN: 247956Hom.: 0 AF XY: 0.000104 AC XY: 14AN XY: 134794
GnomAD4 exome AF: 0.0000602 AC: 88AN: 1461490Hom.: 0 Cov.: 32 AF XY: 0.0000702 AC XY: 51AN XY: 726996
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152270Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74398
ClinVar
Submissions by phenotype
Dyskeratosis congenita, autosomal dominant 2 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 02, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Aug 02, 2016 | The TERT c.3150G>C (p.Lys1050Asn) missense variant has been identified by Collopy et al. (2015) in a homozygous state in one individual and his sister, both of whom have bone marrow failure and nail dystrophy. Both individuals also showed a shortened telomere length. The variant was shown to result in 56% of telomerase activity compared to wild type. The brother was also found to carry a heterozygous variant in the TERC gene which resulted in 4.7% telomerase activity. Control data are unavailable for the p.Lys1050Asn variant, which is reported at a frequency of 0.00047 in the European American population of the Exome Sequencing Project. The evidence for this variant is limited. The p.Lys1050Asn variant is therefore classified as a variant of unknown significance but suspicious for pathogenicity for dyskeratosis congenita. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Oct 15, 2020 | DNA sequence analysis of the TERT gene demonstrated a sequence change, c.3150G>C, in exon 14 that results in an amino acid change, p.Lys1050Asn. This sequence change has been reported in the gnomAD database with a frequency of 0.2% in the Ashkenazi Jewish sub-population (dbSNP rs373400596). The p.Lys1050Asn change affects a moderately conserved amino acid residue located in a domain of the TERT protein that is known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, Revel) provide contradictory results for the p.Lys1050Asn substitution. This sequence change has been described in the homozygous state in one individual with bone marrow failure, nail dystrophy, renal failure, and dental/skin abnormalities, in addition to a novel heterozygous sequence change in the TERC gene. This individual’s sister with bone marrow failure and nail dystrophy was also found to be homozygous for this TERT variant, but did not carry the same variant in TERC (PMID: 26024875). Results of other first-degree relatives from this family were not reported. The p.Lys1050Asn change has been demonstrated to reduce telomerase activity compared with normal controls, however normal telomerase cutoffs have not been well established (PMID: 26024875). A different pathogenic sequence change affecting the same amino acid residue (p.Lys1050Glu) has been described in a patient with pulmonary fibrosis (PMID: 18635888). Due to the frequency of this sequence change in population databases, the p.Lys1050Asn is classified as a variant of unknown significance. - |
Aplastic anemia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 06, 2023 | Published functional studies demonstrate intermediate telomerase activity (Collopy 2015); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 29758336, 27540018, 29463756, 26024875, 26158642, 28495916, 27354474, 29625052, 28104920, 31448843, 32526789) - |
Dyskeratosis congenita Uncertain:1
Uncertain significance, criteria provided, single submitter | curation | Sema4, Sema4 | Jun 15, 2021 | - - |
Idiopathic Pulmonary Fibrosis;C3151443:Dyskeratosis congenita, autosomal dominant 2 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2025 | - - |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at